期刊
NEURON
卷 109, 期 17, 页码 2663-2681出版社
CELL PRESS
DOI: 10.1016/j.neuron.2021.06.023
关键词
-
资金
- National Institutes of Health [R01NS105756, R21AG076201]
- Target ALS Foundation
- Association for Frontotemporal Degeneration
- LiveLikeLou Center for ALS Research at the University of Pittsburgh Brain Institute
Aggregation of RNA-binding proteins is a pathological hallmark of neurodegenerative disorders like ALS and FTD. Recent studies suggest liquid-liquid phase separation may be a critical step in the formation of pathological inclusions. RNA, a common ligand of disease-linked RBPs, plays a crucial role in regulating RBP phase transitions, although it can also antagonize RBP phase behavior in certain conditions.
Aggregation of RNA-binding proteins (RBPs) is a pathological hallmark of neurodegenerative disorders like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In these diseases, TDP-43 and FUS RBPs are depleted from the nuclear compartment, where they are normally localized, and found within cytoplasmic inclusions in degenerating regions of affected individuals' postmortem tissue. The mechanisms responsible for aggregation of these proteins has remained elusive, but recent studies suggest liquid-liquid phase separation (LLPS) might serve as a critical nucleation step in formation of pathological inclusions. The process of phase separation also underlies the formation and maintenance of several functional membrane less organelles (MLOs) throughout the cell, some of which contain TDP-43, FUS, and other disease-linked RBPs. One common ligand of disease-linked RBPs, RNA, is a major component of MLOs containing RBPs and has been demonstrated to be a strong modulator of RBP phase transitions. Although early evidence suggested a largely synergistic effect of RNA on RBP phase separation and MLO assembly, recent work indicates that RNA can also antagonize RBP phase behavior under certain physiological and pathological conditions. In this review, we describe the mechanisms underlying RNA-mediated phase transitions of RBPs and examine the molecular properties of these interactions, such as RNA length, sequence, and secondary structure, that mediate physiological or pathological LLPS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据